TPG announces final close of Asia-focused PE fund

By: |
February 12, 2019 3:46 AM

TPG Asia VII has so far committed more than 40% of the capital across 12 companies.

TPG announces final close of Asia-focused PE fund

Global alternative asset firm TPG announced the final close of its latest Asia-focused private equity fund, TPG Capital Asia VII, on Monday. The fund raised over $4.6 billion in commitments, exceeding its target, TPG said in a statement. TPG Asia VII has so far committed more than 40% of the capital across 12 companies. These include Du Xiaoman, the consumer lending, wealth management and payments platform spun out from Baidu; Pathology Asia Holdings, Healthscope’s Asian Pathology business that operates 39 labs across Singapore, Malaysia and Vietnam; agricultural solutions firm UPL; and Greencross, an ASX-listed integrated pet care platform in Australia, according to the statement.

Read Also| Electronic Manufacturing Summit 2019: UST Global-Kerala govt joint venture laptop gears up for national debut 

Ganen Sarvananthan, co-managing partner for TPG Capital Asia, said that with Asia VII, the fund will continue to invest in opportunities that reflect its differentiated investment strategy, deep sector expertise, and focus on operational improvement.  “We look forward to continuing to deliver value for our investors while helping to build great new companies across Asia,” he said.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Tax Talk: Investing in EPF & Ulips? Take note of I-T changes
2Private health insurers offering 80-100 pc discounts on renewal premia
3Survey finds insurance as most preferred financial product to protect family post-COVID